PETHEALTH SYSTEMS INC
10QSB, 1997-08-12
BLANK CHECKS
Previous: PHOENIX TECHNOLOGIES LTD, 10-Q, 1997-08-12
Next: LIFE USA HOLDING INC /MN/, 10-Q, 1997-08-12



             U.S. SECURITIES AND EXCHANGE COMMISSION
                       Washington, DC 20549



                           FORM 10-QSB



(Mark One)     [X] QUARTERLY REPORT PURSUANT TO SECTION 13
                 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

               For the quarterly period ended June 30, 1997

          [   ] TRANSITION REPORT PURSUANT TO SECTION 13
                 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

               For the transition period from
__________to__________


Commission File Number 000-22151  


                     PETHEALTH SYSTEMS, INC.
(Exact name of small business issuer as specified in its charter)

     Colorado                                     93-0969365
(State or other jurisdiction of                   (IRS Employer
Identification No.)
  incorporation or organization)

              444 Madison Avenue, Suite 1710, New York, NY 10022
             (Address of principal executive offices)

                                 
                          (212) 750-7878
                   (Issuer's telephone number)


Check whether the issuer (1) filed all reports required to be filed
by Section 13 or 15(d) of the Exchange Act during the past 12
months (or for such shorter period that the registrant was required
to file such reports), Yes      No x ; and (2) has been subject to
such filing requirements for the past 90 days. Yes x   No   

1,113,030 shares of Common Stock, no par value, outstanding on
August 1, 1997.           .

             PETHEALTH SYSTEMS, INC. AND SUBSIDIARY
                  Form 10-QSB Quarterly Report
                       Table of Contents


                                                                  
                  Page

PART I -- FINANCIAL INFORMATION

Item 1.  Financial Statements                                              3

     Unaudited Consolidated Balance Sheets at June 30, 1997 and                 
     December 31, 1996                                                     4

     Unaudited Consolidated Statements of Operations For Three and
     Six Months Ended June 30, 1997 and June 30, 1996 and             
     From Inception (December 8, 1981) through June 30, 1997                5

     Unaudited Consolidated Statements of Cash Flows For Six 
     Months Ended June 30, 1997 and 1996 and From Inception 
     (December 8, 1981) to June  30, 1997                                  6

     Statement of Consolidated Stockholders' Equity (Deficit)               7

     Notes to Consolidated Financial Statements                        8 - 10

Item 2.  Management's Discussion and Analysis of                           11
       Financial Condition and Results of Operations                        

PART II -- OTHER INFORMATION                                              12

Item 1.  Legal Proceedings                                                12

Item 2.  Changes in Securities                                            12

Item 3.  Defaults Upon Senior Securities                                  12

Item 4. Submission of Matters to a Vote of Security Holders               12

Item 5.  Other Information                                                12

SIGNATURES                                                                12

PART 1.  FINANCIAL INFORMATION

Item 1. Financial Statements:

BASIS OF PRESENTATION

The accompanying unaudited financial statements are presented in
accordance with generally accepted accounting principles for
interim financial information and the instructions to Form 10-QSB
and item 310 under subpart A of Regulation S-B.   In the opinion of
management, all adjustments considered necessary for a fair
presentation have been included.  Operating results for the six
months ended June 30, 1997 are not necessarily indicative of
results that may be expected for the year ending December 31, 1997. 
For further information, refer to the consolidated financial
statements and footnotes thereto, included in the Company's annual
report on Form 10-KSB for the year ended December 31, 1996, and
Form 8-K filed on July 14, 1997. <PAGE>
            

             PETHEALTH SYSTEMS, INC. AND SUBSIDIARY
                 (A DEVELOPMENT STAGE COMPANY)
                                
            CONSOLIDATED BALANCE SHEETS (UNAUDITED)
                                       June  30,     December 31, 
                                          1997           1996    
                             ASSETS
CURRENT ASSETS:
    Cash in checking                    $    2,933   $        0  

FIXED ASSETS:  
     Equipment net of 
     depreciation of $209               $    2,929   $        0 

OTHER ASSETS:
     Organizational Costs               $      463   $        0
     Investment in Subsidiary           $     (513)  $        0 
          Total Other Assets                   (50)           0 
     TOTAL ASSETS:                      $    5,812   $        0 

            LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT  LIABILITIES:
    Accounts payable                    $    6,782   $    4,307 
     Accrued Expenses                       60,000            0
     
     TOTAL CURRENT LIABILITIES              66,782        4,307 
  

STOCKHOLDERS' (DEFICIT):
     Preferred Stock, $.10 par value,
     100,000,000 shares authorized,
     none issued                                  -           - 

     Common Stock, Class A no par value,
     800,000,000 shares authorized,
     3,285,030 and  285,030 shares
     issued and outstanding                216,954      216,954 

      Common Stock Issuable                 76,000            0

     Deficit accumulated during 
     development stage                    (353,924)    (221,261)

     TOTAL STOCKHOLDERS' (DEFICIT)         (60,970)      (4,307)

TOTAL LIABILITIES AND
     STOCKHOLDERS' EQUITY (DEFICIT)       $  5,812     $      0 

The accompanying notes are an integral part of the financial statements. <PAGE>
  

           PETHEALTH SYSTEMS, INC. AND SUBSIDIARY
                 (A DEVELOPMENT STAGE COMPANY)
             CONSOLIDATED STATEMENTS OF OPERATIONS

                     Three Months Ended  Six Months Ended  For the Period
                           June 30,         June 30,       December 8,1981
                                                           (Inception) to
                          1997    1996       1997     1996     June 30, 1997 
          
Revenues              $   -     $   -      $    -   $    -    $        -    

OPERATING EXPENSES: 
  Legal and accounting  22,199     2,751     41,053    2,975      96,066
  Management services 
      (Note 2)          30,000       -       60,000       -       60,000
  Amortization              25       -           50       -           50 
  Consulting Fees        8,000       -       20,500       -       20,500 
  Depreciation Expense     157       -          209                  209
  Filing and transfer fees 421     1,448      4,749    1,448      13,259 
  Public relations           0        -          -        -       14,414 
  Office and Printing 
      Expense            3,971        -       4,908       -        4,908
  Taxes, Franchise          62        -         660       -          660
  Travel Expenses          534        -         534       -          534
  Other Expenses             -        -          -        -       34,899 

  TOTAL OPERATING 
      EXPENSES          65,369    4,199     132,663    4,423     245,499 

NET (LOSS) BEFORE 
OTHER INCOME (EXPENSES)(65,369)  (4,199)   (132,663)  (4,423)   (245,499)

OTHER INCOME AND (EXPENSES):
   Writeoff of advances
   recision of merger        -        -          -         -    (119,110)

   Forgiveness of debt       -    7,455          -     7,426       7,455 

   Interest income           -        -          -                 3,230

   TOTAL OTHER INCOME 
     (EXPENSES)              -    7,455          -     7,426    (108,425)

NET INCOME (LOSS)    $ (65,369) $ 3,256  $(132,663)   $3,003   $(353,924)     
                                                         
NET (LOSS) PER 
     COMMON SHARE    $       *  $     *  $       *    $    *   $         

WEIGHTED AVERAGE NUMBER OF 
  COMMON SHARES 
  OUTSTANDING        3,285,030  283,215  3,285,030    283,215     N/A   

* less than $.01 net loss per share

The accompanying notes are an integral part of the financial statements.<PAGE>
      

             PETHEALTH SYSTEMS, INC. AND SUBSIDIARY
                 (A DEVELOPMENT STAGE COMPANY)
              CONSOLIDATED STATEMENTS OF CASH FLOWS

                              For the Six Months Ended For the Period
                                        June 30,            December 8,1981
                                    (Unaudited)             (Inception) to
                                  1997          1996        March 31, 1997 
           
  
CASH FLOWS FROM OPERATING ACTIVITIES:

     Net Income (Loss)         $   (132,663)   $     3,003       $     (353,924)
     
     Adjustments to reconcile
     net (loss) to net cash used
     by operating activities:
        Amortization                     50              -                   50
        Depreciation                    209              -                  209 
        Stock issued for
        Services/expenses                 -              -               26,425 

     Changes in operating assets
     and liabilities:
        Increase (decrease) in 
       Current liabilities           62,475         (6,734)              66,782
  
NET CASH (USED) BY
OPERATING ACTIVITIES                (69,929)        (3,731)            (260,458)

CASH FLOWS FROM INVESTING ACTIVITIES:
     Purchased Fixed Assets          (3,138)             -               (3,138)
                                                                                
NET CASH (USED) BY 
INVESTING ACTIVITIES                 (3,138)             0               (3,138)

CASH FLOWS FROM FINANCING ACTIVITIES:
   Proceeds from issuance
     of common stock                 76,000          3,600              327,964 

     Proceeds from issuance
     of Class B common stock              -              -               10,000 

     Deferred offering costs              -              -              (71,435)

NET CASH PROVIDED BY
FINANCING ACTIVITIES                 76,000          3,600              266,529 

NET INCREASE (DECREASE) IN CASH                       (131)              

CASH, BEGINNING OF PERIOD        $    2,933     $      136            $       0
 
CASH, END OF PERIOD              $    2,933     $        5            $   2,933 

The accompanying notes are an integral part of the financial statements.

             PETHEALTH SYSTEMS, INC. AND SUBSIDIARY
                 (A DEVELOPMENT STAGE COMPANY)
   CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)
             For the Six Months Ended June 30, 1997
                                
                                                 Deficit
                                                 Accumulated  Total
                    Number              Common   During       Stockholders'
                    Of                  Stock    Development  Equity
                    Shares     Amount   Issuable Stage        (Deficit)
Balance,
January 1, 1997     57,006,090 $216,954 $     0  $(221,261)   $ (4,307)

PetHealth Systems, 
Inc. acquired all 
of the 3,000,000 
issued and out-
standing shares 
of Common Stock    600,000,000 
of PetCare, Inc. 
in exchange for
600,000,000 shares 
of Common Stock of 
PetHealth Systems, Inc.

1 for 200 Reverse 
  Stock Split     (653,721,060)
   
Monies advanced for 
  Common Stock                            $ 76,000             $ 76,000

Net Loss for the 
  Six Months Ended
 June 30, 1997            --         --       --   $(132,663)  $(132,663)

Balance,
 June 30, 1997      3,285,030    $216,954 $ 76,000 $(353,924)   $(60,970)
     
The accompanying notes are an integral part of the financial statements.

<PAGE>
             PETHEALTH SYSTEMS, INC. AND SUBSIDIARY
                 (A DEVELOPMENT STAGE COMPANY)
                                
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES

PetHealth Systems, Inc., formerly Triangle, Inc. (the "Company") is
a development stage organization formed under the laws of the State
of Colorado on December 8, 1981. Since inception, the Company has
been inactive except for recent organizational and initial
financing efforts. The Company's fiscal year end is December 31,
and there was no activity prior to the year ended December 31,
1988.

     Accounting Method
     The Company records income and expenses on the accrual method.

     Organization Costs
     Costs incurred in organizing the Company are being amortized
     over a sixty-month period.

     Deferred Offering Costs
     The Company incurred costs in connection with its public
     offering. When the offering of the Company's stock was
     successful in April of 1989, these costs were charged as a
     reduction of the proceeds of the offering.

NOTE 2 - RELATED PARTY TRANSACTIONS

Consulting Agreement - Ameristar Group Incorporated.  The Company
has agreed to pay Ameristar Group Incorporated $10,000 per month
for the first 12 months after the first receipt of funds from an
equity financing of the Company, for financial consulting and
general administrative support services which are provided to the
Company by Ameristar Group Incorporated. No payments have been made
as of the date of this report.  Such general administrative support
services have included the provision of office space and equipment,
telephone and other telecommunication services, and administrative
and clerical support staff.  Such agreement was not negotiated at
arms'length due to the relationship between the Company and Mr.
Saposnick and Mr. Messina, directors and record or beneficial
shareholders of the Company.

In 1997, the Company received advances of monies for its operating
expenses from a related company, Ameristar Group Incorporated, in
accordance with an agreement between the two companies. This
Agreement shall be in effect until June 30, 1997 at which time the
parties will determine if this agreement is to be extended or
modified.

             PETHEALTH SYSTEMS, INC. AND SUBSIDIARY
                 (A DEVELOPMENT STAGE COMPANY)
                                
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
                                
NOTE 3 - CAPITALIZATION
In December of 1981, the Company authorized 50,000 shares of no par
value common stock. In March of 1988, the Company amended and
restated its certificate of incorporation to authorize 800,000,000
shares of no par value common stock and 100,000,000 shares of $.10
par value preferred stock. No preferred stock is issued or
outstanding as of June 30, 1997.

NOTE 4 - INCENTIVE STOCK OPTION PLAN

Effective March 3, 1988, the Company adopted an incentive stock
option plan for company executives and key employees. The Company
has reserved 10,000,000 common shares for issuance pursuant to the
plan. The plan provides that no option may be granted at an
exercise price less than the fair market value of the common shares
of the Company on the date of grant and no option can have a term
in excess of ten years. To date, no options have been granted
pursuant to the plan.

NOTE 5 - MERGER AND RELATED RECISION

In August of 1989, the Company consummated an exchange transaction
pursuant to which Triangle acquired all of the outstanding shares
of Enterprise Car Rental, Ltd. d.b.a. Wheels International Rent A
Car ("Wheels") in exchange for 326,500,800 shares of no par value
common stock. In conjunction with the merger, Triangle advanced
$119,110 to Wheels. Effective September 30, 1989, Triangle and
Wheels consummated a Compromise and Settlement Agreement pursuant
to which the merger was reversed. Wheel's shareholders returned all
but 10,000,000 common shares to Triangle in exchange for their
original shares of Wheels to indemnify and hold harmless Triangle
from actions by third parties to Wheels and to secure performance
of obligations of Wheels to cooperate in any legal actions
undertaken by Triangle against third parties of Wheels.

The stockholders' (deficit) in the accompanying financial
statements has been reported as if the merger had not taken place.
The 10,000,000 common shares not returned are recorded as issued in
October of 1989 for no consideration. The advances to Wheels of
$119,110 were written off at December 31, 1989. Management does not
anticipate any further contingencies associated with this failed
merger, however, there is no assurance that there will be no
further contingencies.



             PETHEALTH SYSTEMS, INC. AND SUBSIDIARY
                 (A DEVELOPMENT STAGE COMPANY)
                                
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 - MERGER WITH PETCARE, INC.
On January 29, 1997, an Agreement and Plan of Share Exchange
("Agreement") was entered into by and between the Company and (I)
PetCare, Inc., a Delaware corporation and (ii) the PetCare
shareholders. Under the terms of this Agreement, Triangle, Inc.
acquired all of the 3,000,000 issued and outstanding shares of
common stock of PetCare, Inc. in exchange for 600,000,000 shares of
the common stock of Triangle, Inc. It is intended that this
transaction shall be a tax-free exchange of shares. The Triangle,
Inc. shares are voting shares, are restricted from transfer without
registration under the Securities Act of 1933, as amended, and are
subject to escrow until PetCare completes the acquisition of its
first veterinary hospital.

NOTE 7 - SUBSEQUENT EVENT

The Company has been unable to raise the capital required to
implement the PetCare, Inc, business plan (acquisition of operating
veterinarian hospitals and consolidation of operations thereof). 
Therefore, as of July 7, 1997, PetHealth Systems, Inc. and the
former principal shareholders of PetCare, Inc., have agreed to the
cancellation of the Agreement and Plan of Share Exchange.

Upon the cancellation of the original agreement, 2,700,000 of the
3,000,000 shares of the common stock (which the Company originally
had issued to the five principal shareholders of PetCare, Inc.)
were returned to the company for cancellation.  No consideration
was provided by the company, or any third party, in connection with
such return of shares.  The remaining 300,000 shares of common
stock which had been originally issued to minority shareholders of
PetCare, Inc. for services provided to PetCare, Inc. prior to its
acquisition by the registrant, will not be returned to the
registrant for cancellation.

NOTE 8 - NAME CHANGED

The corporate name has been changed from Triangle, Inc. to
PetHealth Systems, Inc. effective February 10, 1997.

<PAGE>
Item 2.  Management's Discussion and Analysis of Financial
Conditions and Results of Operations:

Acquisition of PetCare, Inc.

An Agreement and Plan of Share Exchange ("Exchange Agreement")
between Triangle, Inc. and PetCare, Inc. was entered into on
January 29, 1997.  Effective February 10, 1997, pursuant to the
Exchange Agreement, Triangle, Inc. acquired all of the outstanding
shares of Common Stock of PetCare, Inc. from its shareholders in
exchange for 3,000,000 (post-split) restricted shares of Common
Stock of Triangle, Inc. issued to those shareholders.  Also, the
name of the registrant was changed from Triangle, Inc. to PetHealth
Systems, Inc., new Directors were elected and the former Directors
resigned, and the outstanding shares of Common Stock of the
registrant were subjected to a 1 for 200 reverse split, effective
February 24, 1997.

As a result of the closing of the Exchange Agreement, the business
of the registrant as of the end of the period covered by this
Report was to purchase and operate companion pet veterinary
hospital practices which meet certain financial criteria and
demographic profiles for growth.  However, subsequent to the end of
such period, the registrant has determined that the PetCare
business plan is not viable, and such business plan will no longer
be pursued.  Reference is made to the Form 8-K Report filed in
July, 1997.

Results of Operations

The Company did not have any operating income during the six month
period ended June 30, 1997, and has not had any operating income
since its inception.  For this period, the registrant recognized a
net loss of $ 65,369 compared to net income of $3,256 for the
period ended June 30, 1996.  General and administrative expenses
during the current period were funded by Ameristar Capital
Corporation, a private corporation affiliated with two directors of
the registrant (who resigned subsequent to the end of the period). 
Expenses were comprised of costs associated with audit, legal and
SEC reporting obligations, and by a limited amount of equity
capital raised in the prior quarter.

In March 1997, the registrant received proceeds of $76,000 from
private equity financing.  No further equity capital was raised in
the quarter ended June 30, 1997.

Liquidity and Capital Resources

At June 30, 1997 the Company had no capital resources other than an
insignificant amount of cash. 
<PAGE>
PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.    Not applicable.

Item 2.   Changes in Securities.   

     Not applicable for the period covered by this report. 
     However, there has been a change in control of the Company
     after the close of the period covered by this Report, as
     disclosed in the Form 8-K Report filed in July, 1997.

Item 3.   Defaults Upon Senior Securities.    Not Applicable.

Item 4.   Submission of Matters to a Vote of Security Holders.   
          Not Applicable.
     
Item 5.   Other Information.    None.

Item 6.   Exhibits and Reports of Form 8-K.    None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed in its behalf by the undersigned,
thereunto duly authorized, on August     , 1997.

          PETHEALTH SYSTEMS, INC.

          By:/s/Robert Gordon                                     
               Robert Gordon 
               President 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission